Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis

Andreina Baj,Elisabetta Moro,Michela Bistoletti,Viviana Orlandi,Francesca Crema,Cristina Giaroni

DOI: https://doi.org/10.3390/ijms20061482

IF: 5.6

2019-03-25

International Journal of Molecular Sciences

Abstract:A complex bidirectional communication system exists between the gastrointestinal tract and the brain. Initially termed the “gut-brain axis” it is now renamed the “microbiota-gut-brain axis” considering the pivotal role of gut microbiota in maintaining local and systemic homeostasis. Different cellular and molecular pathways act along this axis and strong attention is paid to neuroactive molecules (neurotransmitters, i.e., noradrenaline, dopamine, serotonin, gamma aminobutyric acid and glutamate and metabolites, i.e., tryptophan metabolites), sustaining a possible interkingdom communication system between eukaryota and prokaryota. This review provides a description of the most up-to-date evidence on glutamate as a neurotransmitter/neuromodulator in this bidirectional communication axis. Modulation of glutamatergic receptor activity along the microbiota-gut-brain axis may influence gut (i.e., taste, visceral sensitivity and motility) and brain functions (stress response, mood and behavior) and alterations of glutamatergic transmission may participate to the pathogenesis of local and brain disorders. In this latter context, we will focus on two major gut disorders, such as irritable bowel syndrome and inflammatory bowel disease, both characterized by psychiatric co-morbidity. Research in this area opens the possibility to target glutamatergic neurotransmission, either pharmacologically or by the use of probiotics producing neuroactive molecules, as a therapeutic approach for the treatment of gastrointestinal and related psychiatric disorders.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the following aspects:

1. **Clarify the role of glutamate in the microbiota - gut - brain axis**: The paper elaborately describes the latest evidence of glutamate as a neurotransmitter/neuromodulator in the two - way communication axis of the microbiota - gut - brain. By regulating its receptor activity, glutamate may affect gut functions (such as taste, visceral sensitivity and motility) and brain functions (such as stress response, mood and behavior).

2. **Explore the relationship between abnormal glutamatergic transmission and diseases**: The paper points out that changes in glutamatergic transmission may be involved in the pathogenesis of local and brain diseases. Especially in two major gut diseases - irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), these diseases are often accompanied by psychiatric comorbidities.

3. **Explore treatment strategies targeting glutamatergic neurotransmission**: Research the possibilities in this area, aiming at using traditional drug methods or probiotics that produce neuroactive molecules as new therapies for gastrointestinal and related mental disorders.

By reviewing the above content, the paper aims to deepen the understanding of glutamatergic signaling in the microbiota - gut - brain axis and provide new perspectives and potential approaches for the treatment of related diseases.